Colin Bristow
Stock Analyst at UBS
Total Price Targets
12
Stocks Covered
9
Sectors
Healthcare
Most Recent
Aug 26, 2024
Stocks Covered by Colin Bristow
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| PTCT | PTC Therapeutics, Inc. | $47.00 | $60.56 | -22.4% | 2 | Aug 26, 2024 |
| MRK | Merck & Co., Inc. | $142.00 | $150.05 | -5.4% | 2 | Jul 31, 2024 |
| ALXO | ALX Oncology Holdings Inc. | $25.00 | $1.23 | +1940.8% | 1 | Jun 10, 2024 |
| AMGN | Amgen Inc. | $307.00 | $466.55 | -34.2% | 2 | May 3, 2024 |
| IMVT | Immunovant, Inc. | $5.00 | $29.19 | -82.9% | 1 | Sep 26, 2022 |
| GILD | Gilead Sciences, Inc. | $54.00 | $171.59 | -68.5% | 1 | Feb 24, 2022 |
| PFE | Pfizer Inc. | $60.00 | $30.43 | +97.2% | 1 | Dec 13, 2021 |
| BIIB | Biogen Inc. | $405.00 | $253.33 | +59.9% | 1 | Oct 20, 2021 |
| VRTX | Vertex Pharmaceuticals Incorporated | $279.00 | $558.56 | -50.1% | 1 | May 12, 2021 |
Recent Activity
- Aug 26, 2024— Set$47.00price target onPTCT(PTC Therapeutics, Inc.)
- Jul 31, 2024— Set$142.00price target onMRK(Merck & Co., Inc.)
- Jun 10, 2024— Set$25.00price target onALXO(ALX Oncology Holdings Inc.)
- May 3, 2024— Set$307.00price target onAMGN(Amgen Inc.)
- Sep 26, 2022— Set$5.00price target onIMVT(Immunovant, Inc.)
- Feb 24, 2022— Set$54.00price target onGILD(Gilead Sciences, Inc.)
- Feb 8, 2022— Set$232.00price target onAMGN(Amgen Inc.)
- Dec 13, 2021— Set$76.00price target onMRK(Merck & Co., Inc.)
- Dec 13, 2021— Set$60.00price target onPFE(Pfizer Inc.)
- Oct 20, 2021— Set$405.00price target onBIIB(Biogen Inc.)
- Aug 31, 2021— Set$45.00price target onPTCT(PTC Therapeutics, Inc.)
- May 12, 2021— Set$279.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
Frequently Asked Questions
Who is Colin Bristow?
Colin Bristow is a stock analyst at UBS covering 9 stocks primarily in Healthcare. They have issued 12 price targets since May 12, 2021.
What stocks does Colin Bristow cover?
Colin Bristow currently covers 9 stocks, including PTCT, MRK, AMGN, ALXO, IMVT.
What is Colin Bristow's latest price target?
Colin Bristow's most recent price target was $47.00 on PTCT (PTC Therapeutics, Inc.), set on Aug 26, 2024.
What is Colin Bristow's highest price target?
Colin Bristow's highest issued price target is $405.00 on BIIB, set on Oct 20, 2021.
More Analysts at UBS
Coverage based on publicly published price targets. Not investment advice.